| |
| |
|
| Insider
Information: |
Gannon Steven |
| Relationship: |
Director |
| City: |
Burnaby |
| State: |
A1 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
58,400 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$1,208,088 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
58,400 |
|
|
| Total
Value |
$1,208,088 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
5
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
4
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -17.6%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xenon Pharmaceuticals Inc. |
XENE |
|
2024-03-07 |
2,000 |
2017-08-11 |
0 |
Premium* |
|
|
Fusion Pharmaceuticals Inc. |
FUSN |
Director |
2022-08-11 |
56,400 |
2021-08-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
7 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| XENE |
Xenon Pharmaceuticals Inc... |
|
– • – |
2024-03-07 |
4 |
S |
$46.20 |
$601,615 |
D/D |
(13,000) |
2,000 |
0 |
- |
|
| FUSN |
Fusion Pharmaceuticals In... |
Director |
– • – |
2022-08-11 |
4 |
B |
$2.03 |
$90,132 |
D/D |
44,400 |
56,400 |
2.39 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Director |
– • – |
2021-08-23 |
4 |
B |
$7.99 |
$22,590 |
D/D |
2,829 |
12,000 |
2.39 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Director |
– • – |
2021-08-19 |
4 |
B |
$8.05 |
$24,150 |
D/D |
3,000 |
9,171 |
2.39 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Director |
– • – |
2021-08-18 |
4 |
B |
$8.05 |
$1,377 |
D/D |
171 |
6,171 |
2.31 |
% |
|
| FUSN |
Fusion Pharmaceuticals In... |
Director |
– • – |
2021-08-16 |
4 |
B |
$8.10 |
$48,600 |
D/D |
6,000 |
6,000 |
2.39 |
% |
|
| XENE |
Xenon Pharmaceuticals Inc... |
Director |
– • – |
2017-08-11 |
4 |
B |
$2.82 |
$42,267 |
D/D |
15,000 |
15,000 |
2.39 |
- |
|
7 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
